Literature DB >> 19178662

NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging.

M V P Nadella1, W C Kisseberth, K S Nadella, N K Thudi, D H Thamm, E A McNiel, A Yilmaz, K Boris-Lawrie, T J Rosol.   

Abstract

Lymphoma is a malignant neoplasm arising from B or T lymphocytes. In dogs, one-third of lymphomas are highly aggressive multicentric T-cell lymphomas that are often associated with humoral hypercalcaemia of malignancy (HHM). There are no cell lines or animal models to investigate the pathogenesis of T-cell lymphoma and HHM in dogs. We developed the first xenograft model by injecting lymphoma cells from an Irish Wolfhound intraperitoneally into NOD/SCID mice. The mice developed multicentric lymphoma along with HHM and increased parathyroid hormone-related protein (PTHrP) as occurs in dogs with T-cell lymphoma. Using cytokine complementary DNA arrays, we identified genes that have potential implications in the pathogenesis of T-cell lymphoma. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) of T-cell lymphoma samples from hypercalcaemic canine patients showed that PTHrP likely plays a central role in the pathogenesis of HHM and that hypercalcaemia is the result of a combinatorial effect of different hypercalcaemic factors. Finally, we monitored in vivo tumour progression and metastases in the mouse model by transducing the lymphoma cells with a lentiviral vector that encodes a luciferase-yellow fluorescent protein reporter and showed that in vivo trafficking patterns in this model were similar to those seen in dogs. This unique mouse model will be useful for translational research in lymphoma and for investigating the pathogenesis of T-cell lymphoma and HHM in the dog.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19178662      PMCID: PMC2832741          DOI: 10.1111/j.1476-5829.2007.00139.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  64 in total

1.  Effects of interleukin-1 on bone turnover in normal mice.

Authors:  B F Boyce; T B Aufdemorte; I R Garrett; A J Yates; G R Mundy
Journal:  Endocrinology       Date:  1989-09       Impact factor: 4.736

Review 2.  Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment.

Authors:  E G MacEwen
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

Review 3.  Parathyroid hormone-related protein (PTHrP): studies with synthetic peptides indicate that parathyroid hormone and PTHrP interact with the same receptor.

Authors:  M P Caulfield; R L McKee; M E Goldman; M A Thiede; D D Thompson; J E Fisher; J J Levy; J G Seedor; N Horiuchi; T L Clemens
Journal:  Int J Rad Appl Instrum B       Date:  1990

Review 4.  Pathophysiology of cancer-associated hypercalcemia.

Authors:  G R Mundy
Journal:  Semin Oncol       Date:  1990-04       Impact factor: 4.929

5.  Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+ memory T cells with Hallmarks of gut-trophism.

Authors:  T Schweighoffer; Y Tanaka; M Tidswell; D J Erle; K J Horgan; G E Luce; A I Lazarovits; D Buck; S Shaw
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

6.  Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer.

Authors:  S C Kukreja; T J Rosol; S A Wimbiscus; D H Shevrin; V Grill; E I Barengolts; T J Martin
Journal:  Endocrinology       Date:  1990-07       Impact factor: 4.736

Review 7.  Mechanisms of cancer-induced hypercalcemia.

Authors:  T J Rosol; C C Capen
Journal:  Lab Invest       Date:  1992-12       Impact factor: 5.662

8.  A tumor-secreted protein associated with human hypercalcemia of malignancy. Biology and molecular biology.

Authors:  M Rosenblatt; M P Caulfield; J E Fisher; N Horiuchi; R L Mckee; S B Rodan; M A Thiede; D D Thompson; J G Seedor; R E Nutt
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

9.  Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.

Authors:  T J Rosol; L A Nagode; C G Couto; A S Hammer; D J Chew; J L Peterson; R D Ayl; C L Steinmeyer; C C Capen
Journal:  Endocrinology       Date:  1992-09       Impact factor: 4.736

10.  Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice.

Authors:  T Yoneda; M A Alsina; J B Chavez; L Bonewald; R Nishimura; G R Mundy
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

View more
  6 in total

1.  Establishment of a Patient-Derived Xenograft of Canine Enteropathy-Associated T-Cell Lymphoma, Large Cell Type.

Authors:  K S Im; J H Kim; A J Graef; I Cornax; D M Seelig; M G O'Sullivan; R C Kovi; J F Modiano
Journal:  J Comp Pathol       Date:  2016-12-20       Impact factor: 1.311

Review 2.  Animal Models of Bone Metastasis.

Authors:  J K Simmons; B E Hildreth; W Supsavhad; S M Elshafae; B B Hassan; W P Dirksen; R E Toribio; T J Rosol
Journal:  Vet Pathol       Date:  2015-05-28       Impact factor: 2.221

3.  Development of a brain metastatic canine prostate cancer cell line.

Authors:  Nanda K Thudi; Sherry T Shu; Chelsea K Martin; Lisa G Lanigan; Murali V P Nadella; Adrie Van Bokhoven; Jillian L Werbeck; Jessica K Simmons; Sridhar Murahari; William C Kisseberth; Matthew Breen; Christina Williams; Ching-Shih Chen; Laurie K McCauley; Evan T Keller; Thomas J Rosol
Journal:  Prostate       Date:  2011-02-14       Impact factor: 4.104

4.  Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases.

Authors:  Nanda K Thudi; Chelsea K Martin; Sridhar Murahari; Sherry T Shu; Lisa G Lanigan; Jillian L Werbeck; Evan T Keller; Laurie K McCauley; Joseph J Pinzone; Thomas J Rosol
Journal:  Prostate       Date:  2010-10-18       Impact factor: 4.104

Review 5.  Animal Models of Cancer-Associated Hypercalcemia.

Authors:  Nicole A Kohart; Said M Elshafae; Justin T Breitbach; Thomas J Rosol
Journal:  Vet Sci       Date:  2017-04-13

6.  Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies.

Authors:  Joana N R Dias; Ana S André; Sandra I Aguiar; Joana Ministro; Joana Oliveira; Maria C Peleteiro; Barbara Rütgen; Lurdes Gano; João D G Correia; Soraia S Oliveira; Joao Goncalves; Solange Gil; Luís Tavares; Frederico Aires-da-Silva
Journal:  PLoS One       Date:  2018-12-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.